Free equity investment tool of Japanese companies

Financial Statement Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

中外製薬

HISAMITSU PHARMACEUTICAL

塩野義製薬

キョーリン製薬ホールディングス

DAIICHI SANKYO

エスケー化研

JSR

TSUMURA & CO.

Shin-Etsu Chemical

Fuso Pharmaceutical Industries

関西ペイント

The Nippon Synthetic Chemical Industry

ダイセル

NIPPON PAINT

Nihon Parkrizing

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

10/30 Real Estate (DAIBIRU:BBB→A e..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Hitachi Zosen etc.

NIPPON COKE & ENGINEERING

メルコホールディングス

ROHM

日本セラミック etc.

Financial Statement Details: DAIICHI SANKYO+JSR (Annual )

Two or more periods are displayed by each of subject collectively.Two or more companies can be compared and financial statement data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Statement data

F/S Outline: DAIICHI SANKYO+JSR (Annual )

Switch ViewU-ChartU-Chart and F/SF/S

Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large
U-Chart	DAIICHI SANKYO (2013-03-31)	JSR (2013-03-31)
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
	[BS] 2013-03-31  *  Total: ¥ 1.6 T  *  Net: ¥ 915 B  (Ratio: 55.70%)	[BS] 2013-03-31  *  Total: ¥ 482 B  *  Net: ¥ 315 B  (Ratio: 65.38%)
Financial Statement Details	DAIICHI SANKYO (2013-03-31)	JSR (2013-03-31)
Cash etc.	¥ 160 B	¥ 32 B
Other Current Assets	¥ 782 B	¥ 288 B
Tangible Assets	¥ 303 B	¥ 93 B
Intangible Assets	¥ 223 B	¥ 6 B
Investment etc.	¥ 173 B	¥ 63 B
Total Assets	¥ 1.6 T	¥ 482 B
Current Liabilities	¥ 436 B	¥ 141 B
Fixed Liabilities	¥ 292 B	¥ 25 B
Capital stock	¥ 50 B	¥ 23 B
Capital surplus etc.	¥ 865 B	¥ 292 B
Liabilities and net assets	¥ 1.6 T	¥ 482 B
Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large
U-Chart	DAIICHI SANKYO (2013-03-31)	JSR (2013-03-31)
Sales Cost of Sales Other income SG&A Other expenses Net income	*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
	[PL] 2013-03-31  *  Sales: ¥ 997 B  *  Income: ¥ 66 B  (Ratio: 6.68%)	[PL] 2013-03-31  *  Sales: ¥ 371 B  *  Income: ¥ 30 B  (Ratio: 8.15%)
Financial Statement Details	DAIICHI SANKYO (2013-03-31)	JSR (2013-03-31)
Sales	¥ 997 B	¥ 371 B
Cost of Sales	¥ 313 B	¥ 279 B
Gross profit	¥ 684 B	¥ 92 B
Other income	¥ 29 B	¥ 9 B
SG&A	¥ 583 B	¥ 57 B
Other expenses	¥ 62 B	¥ 14 B
Net income	¥ 66 B	¥ 30 B
Consolidated :Cash flow statement (C/F) Consolidated | Non-Consolidated | Small | Large
U-Chart	DAIICHI SANKYO (2013-03-31)	JSR (2013-03-31)
Operating CF Investment CF Financial CF Foreign Exchange Effects Net Change in Cash	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Cash)
	[CF] 2013-03-31  *  OCF: ¥ 129 B  *  Cash: ¥ -21 B	[CF] 2013-03-31  *  OCF: ¥ 47 B  *  Cash: ¥ -19 B
Financial Statement Details	DAIICHI SANKYO (2013-03-31)	JSR (2013-03-31)
Operating CF	¥ 129 B	¥ 47 B
Investment CF	¥ -109 B	¥ -58 B
Financial CF	¥ -57 B	¥ -10 B
Foreign Exchange Effects	¥ 15 B	¥ 1 B
Net Change in Cash	¥ -21 B	¥ -19 B
Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large
U-Chart	DAIICHI SANKYO (2013-03-31)	JSR (2013-03-31)
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
	[SS] 2013-03-31  *  Income: ¥ 66 B  *  Net: ¥ +82 B	[SS] 2013-03-31  *  Income: ¥ 30 B  *  Net: ¥ +33 B
Financial Statement Details	DAIICHI SANKYO (2013-03-31)	JSR (2013-03-31)
Issuance of new shares	-	-
Dividends from surplus	¥ -42 B	¥ -7 B
Net income	¥ 66 B	¥ 30 B
Purchase of treasury stock	¥ 43 M	¥ -5 B
Other Change in Stockholders Equity	¥ -1 M	¥ -52 M
Other Change in Net Assets	¥ 58 B	¥ 17 B
Net Change in Net Assets	¥ 82 B	¥ 33 B

Non-Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large
U-Chart	DAIICHI SANKYO (2013-03-31)	JSR (2013-03-31)
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
	[BS] 2013-03-31  *  Total: ¥ 1.1 T  *  Net: ¥ 803 B  (Ratio: 68.43%)	[BS] 2013-03-31  *  Total: ¥ 394 B  *  Net: ¥ 250 B  (Ratio: 63.41%)
Financial Statement Details	DAIICHI SANKYO (2013-03-31)	JSR (2013-03-31)
Cash etc.	-	¥ 15 B
Other Current Assets	-	¥ 246 B
Tangible Assets	-	¥ 57 B
Intangible Assets	-	¥ 2 B
Investment etc.	¥ 1.1 T	¥ 72 B
Total Assets	¥ 1.1 T	¥ 394 B
Current Liabilities	¥ 370 B	¥ 128 B
Fixed Liabilities	-	¥ 16 B
Capital stock	-	¥ 23 B
Capital surplus etc.	¥ 803 B	¥ 227 B
Liabilities and net assets	¥ 1.1 T	¥ 394 B
Non-Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large
U-Chart	DAIICHI SANKYO (2013-03-31)	JSR (2013-03-31)
Sales Cost of Sales Other income SG&A Other expenses Net income	*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
	[PL] 2013-03-31  *  Sales: ¥ 549 B  *  Income: ¥ 55 B  (Ratio: 10.15%)	[PL] 2013-03-31  *  Sales: ¥ 258 B  *  Income: ¥ 21 B  (Ratio: 8.45%)
Financial Statement Details	DAIICHI SANKYO (2013-03-31)	JSR (2013-03-31)
Sales	¥ 549 B	¥ 258 B
Cost of Sales	¥ 494 B	¥ 195 B
Gross profit	¥ 55 B	¥ 63 B
Other income	-	¥ 8 B
SG&A	-	¥ 36 B
Other expenses	-	¥ 13 B
Net income	¥ 55 B	¥ 21 B
Non-Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large
U-Chart	DAIICHI SANKYO (2013-03-31)	JSR (2013-03-31)
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
	-	[SS] 2013-03-31  *  Income: ¥ 21 B  *  Net: ¥ +12 B
Financial Statement Details	DAIICHI SANKYO (2013-03-31)	JSR (2013-03-31)
Issuance of new shares	-	-
Dividends from surplus	-	¥ -7 B
Net income	-	¥ 21 B
Purchase of treasury stock	-	¥ -5 B
Other Change in Stockholders Equity	-	-
Other Change in Net Assets	-	¥ 4 B
Net Change in Net Assets	-	¥ 12 B

Related Information: DAIICHI SANKYO  JSR 

Statement Type

Annual : DAIICHI SANKYO+JSR

First quarter : DAIICHI SANKYO+JSR

Second quarter : DAIICHI SANKYO+JSR

Third quarter : DAIICHI SANKYO+JSR

Analysis Menu

Outline : DAIICHI SANKYO+JSR

Statement : DAIICHI SANKYO+JSR

Rating : DAIICHI SANKYO+JSR

Indicator : DAIICHI SANKYO+JSR

Download : DAIICHI SANKYO+JSR

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo中央区 - EDIUNET Prefectures

Tokyo港区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
DAIICHI SANKYO	4568	TSE 1st	Chemicals	3	Annual	BB
JSR	4185	TSE 1st	Chemicals	3	Annual	A

Related Company

Fuso Pharmaceutical Industries (Sales ¥ 48 B)

DAIICHI SANKYO (Sales ¥ 997 B)

Otsuka Holdings (Sales ¥ 1.2 T)

大正製薬ホールディングス (Sales ¥ 285 B)

TSUMURA & CO. (Sales ¥ 105 B)

Kao (Sales ¥ 1.2 T)

The Nippon Synthetic Chemical Industry (Sales ¥ 91 B)

ダイセル (Sales ¥ 358 B)

富士製薬工業 (Sales ¥ 25 B)

アステラス製薬 (Sales ¥ 1.0 T)

エスケー化研 (Sales ¥ 82 B)

関西ペイント (Sales ¥ 294 B)

塩野義製薬 (Sales ¥ 282 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .